EUVIMEDEUVIMED entdecken
Crossref

Emerging Ceftriaxone Resistance in Paediatric Shigella sonnei : A 10‐Year Retrospective Study

Antoni Skripai iD, Aviv Katz, Jonathan Lellouche, Ori Trabelsi, Nechama Sharon iD

Acta Paediatrica · 2026-05 · 115 (5) · 1063-1069

DOI: 10.1111/apa.70449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Paediatrica, online erschienen am 19.01.2026. Verfasst von Antoni Skripai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Laniado Hospital, Netanya, Israel. Hauptthemen laut MEDLINE: Shigella sonnei, Dysentery, Bacillary, Ceftriaxone, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study's aim is to evaluate temporal trends in antimicrobial resistance in Shigella sonnei , with a focus on the emergence of ceftriaxone‐resistant strains among paediatric patients.

Methods

We conducted a 10‐year retrospective study of all paediatric patients diagnosed with Shigella sonnei via stool culture in our emergency department. Clinical features, laboratory results, and length of hospital stay were reviewed to assess trends in ceftriaxone resistance and compare between resistant and sensitive groups.

Results

We analysed 180 paediatric Shigella sonnei cases. Of these, 177 (98.3%) were tested for ceftriaxone susceptibility: 156 (88.1%) were sensitive, and 21 (11.9%) resistant. Resistant strains emerged in 2022 (85.7%, 6/7), rising to 88.2% (15/17) in 2023, showing a strong correlation with calendar year ( p < 0.001). Resistant cases showed lower neutrophil ( p < 0.01) and sodium levels ( p < 0.006).

Conclusion

Ceftriaxone‐resistant Shigella sonnei has risen sharply in Israel since 2022, mirroring global trends. This highlights the urgent need for strengthened antimicrobial resistance surveillance and to update current guidelines for the empiric treatment of childhood shigellosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shigella sonneiDysentery, BacillaryCeftriaxoneAnti-Bacterial AgentsDrug Resistance, BacterialHumansRetrospective StudiesChild, PreschoolFemaleChildMaleIsraelInfantThird Generation CephalosporinsMicrobial Sensitivity Tests

Substanzen

CeftriaxoneAnti-Bacterial AgentsThird Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Pediatrics, Laniado Hospital, Netanya, Israel.
  • School of Medicine, Hebrew University, Jerusalem, Israel.
  • Department of Clinical Laboratories, Laniado Hospital, Netanya, Israel.
  • Adelson School of Medicine, Ariel University, Ariel, Israel.

ORCID-Profile: Antoni Skripai, Nechama Sharon

Zitieren

APA

Skripai, A., Katz, A., Lellouche, J., Trabelsi, O., & Sharon, N. (2026). Emerging Ceftriaxone Resistance in Paediatric Shigella sonnei : A 10‐Year Retrospective Study. Acta Paediatrica, 115(5), 1063-1069. https://doi.org/10.1111/apa.70449

Vancouver

Skripai A, Katz A, Lellouche J, Trabelsi O, Sharon N. Emerging Ceftriaxone Resistance in Paediatric Shigella sonnei : A 10‐Year Retrospective Study. Acta Paediatrica. 2026;115(5):1063-1069. doi:10.1111/apa.70449

BibTeX
@article{Skripai2026,
  author = {Skripai, Antoni and Katz, Aviv and Lellouche, Jonathan and Trabelsi, Ori and Sharon, Nechama},
  title = {Emerging Ceftriaxone Resistance in Paediatric Shigella sonnei : A 10‐Year Retrospective Study},
  journal = {Acta Paediatrica},
  year = {2026},
  volume = {115},
  number = {5},
  pages = {1063--1069},
  doi = {10.1111/apa.70449}
}
Kostenlos starten →